Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    October 2017
  1. SPEHALSKI E, Capper KM, Smith CJ, Morgan MJ, et al
    MRE11 Promotes Tumorigenesis by Facilitating Resistance to Oncogene-Induced Replication Stress.
    Cancer Res. 2017;77:5327-5338.
    PubMed     Text format     Abstract available


  2. TANG YC, Yuwen H, Wang K, Bruno PM, et al
    Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.
    Cancer Res. 2017;77:5272-5286.
    PubMed     Text format     Abstract available


    September 2017
  3. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    PubMed     Text format     Abstract available


  4. HERRMANN A, Lahtz C, Nagao T, Song JY, et al
    CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
    Cancer Res. 2017;77:5118-5128.
    PubMed     Text format     Abstract available


    July 2017
  5. FEELEY KP, Adams CM, Mitra R, Eischen CM, et al
    Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells.
    Cancer Res. 2017;77:3823-3833.
    PubMed     Text format     Abstract available


  6. O'STEEN S, Green DJ, Gopal AK, Orozco JJ, et al
    Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.
    Cancer Res. 2017;77:3885-3893.
    PubMed     Text format     Abstract available


    May 2017
  7. DAHAL LN, Dou L, Hussain K, Liu R, et al
    STING activation reverses lymphoma-mediated resistance to antibody immunotherapy.
    Cancer Res. 2017 May 16. pii: canres.2784.2016.
    PubMed     Text format     Abstract available


  8. GREEN DJ, Press OW
    Whither Radioimmunotherapy: To Be or Not To Be?
    Cancer Res. 2017;77:2191-2196.
    PubMed     Text format     Abstract available


  9. DEUTSCH AJA, Rinner B, Pichler M, Prochazka K, et al
    NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
    Cancer Res. 2017;77:2375-2386.
    PubMed     Text format     Abstract available


    March 2017
  10. MANFROI B, McKee T, Mayol JF, Tabruyn S, et al
    CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.
    Cancer Res. 2017;77:1097-1107.
    PubMed     Text format     Abstract available


    January 2017
  11. DU W, Goldstein R, Jiang Y, Aly O, et al
    Effective combination therapies for B cell lymphoma predicted by a virtual disease model.
    Cancer Res. 2017 Jan 27. pii: canres.0476.2016.
    PubMed     Text format     Abstract available


  12. SPATH F, Wibom C, Krop EJ, Johansson AS, et al
    Biomarker dynamics in B-cell lymphoma: a longitudinal prospective study of plasma samples up to 25 years before diagnosis.
    Cancer Res. 2017 Jan 20. pii: canres.2345.2016.
    PubMed     Text format     Abstract available


    October 2016
  13. LIU Y, Pandeswara S, Dao V, Padron A, et al
    Biphasic rapamycin effects in lymphoma and carcinoma treatment.
    Cancer Res. 2016 Oct 13. pii: canres.1140.2016.
    PubMed     Text format     Abstract available


    September 2016
  14. TAKAHASHI N, Sugaya M, Suga H, Oka T, et al
    Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T cell lymphoma.
    Cancer Res. 2016 Sep 6. pii: canres.0992.2016.
    PubMed     Text format     Abstract available


    August 2016
  15. ZHANG H, Chen Z, Miranda RN, Medeiros LJ, et al
    TG2 and NF-kB signaling coordinates the survival of mantle cell lymphoma cells via IL-6-mediated autophagy.
    Cancer Res. 2016 Aug 3. pii: canres.0595.2016.
    PubMed     Text format     Abstract available


    April 2016
  16. RAO S, Cai KQ, Stadanlick JE, Greenberg-Kushnir N, et al
    Ribosomal protein Rpl22 controls the dissemination of T cell lymphoma.
    Cancer Res. 2016 Apr 5. pii: canres.2698.2015.
    PubMed     Text format     Abstract available


    March 2016
  17. RAVI D, Beheshti A, Abermil N, Passero F, et al
    Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC Dependent Cell Death in T-Cell and Hodgkin Lymphoma.
    Cancer Res. 2016 Mar 17. pii: canres.2477.2015.
    PubMed     Text format     Abstract available



  18. Correction: The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration.
    Cancer Res. 2016;76:1669.
    PubMed     Text format    


  19. DEVITA VT JR, DeVita-Raeburn E, Moxley JH 3rd
    Intensive Combination Chemotherapy and X-Irradiation in Hodgkin's Disease.
    Cancer Res. 2016;76:1303-4.
    PubMed     Text format    


    February 2016
  20. KUMAR R
    Observations on Radiation-Induced Lymphoid Tumors of Mice.
    Cancer Res. 2016;76:511-2.
    PubMed     Text format    


    November 2015
  21. BISIKIRSKA B, Bansal M, Shen Y, Teruya-Feldstein J, et al
    Elucidation and pharmacological targeting of novel molecular drivers of follicular lymphoma progression.
    Cancer Res. 2015 Nov 20. pii: canres.0828.2015.
    PubMed     Text format     Abstract available


    September 2015
  22. POIROT L, Philip B, Schiffer-Mannioui C, Le Clerre D, et al
    Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.
    Cancer Res. 2015;75:3853-64.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: